Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer

British Journal of Cancer

Volumn 112, Issue 11, 2015, Pages 1782-1790

  Hiraoka, N ^a,b   Ino, Y ^a   Yamazaki Itoh, R ^a,b   Kanai, Y ^a   Kosuge, T ^b   Shimada, K ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

pancreatic cancer; tertiary lymphoid organ; tumour immunity; vessel

Indexed keywords

ADULT; AGE; ARTERIOLE; ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CANCER TISSUE; CAPILLARY; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPHOCYTIC INFILTRATION; LYMPHOID ORGAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NERVE PLEXUS; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREATIC DUCTAL CARCINOMA; PERICYTE; PRIORITY JOURNAL; SURVIVAL FACTOR; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TUMOR INVASION; TUMOR MICROENVIRONMENT; VENULE; AGED; CARCINOMA, PANCREATIC DUCTAL; IMMUNOLOGY; LYMPHOCYTE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

AGED; B-LYMPHOCYTES; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MICROENVIRONMENT;

EID: 84930042269     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.145     Document Type: Article

References (31)

1. Carmeliet P, Jain RK. (2011). Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10: 417-427
2. Carragher DM, Rangel-Moreno J, Randall TD. (2008). Ectopic lymphoid tissues and local immunity. Semin Immunol 20: 26-42
3. Center for Cancer Control and Information Services and National Cancer Center J. (2009). Cancer Statistics in Japan. Foundation for Promotion of Cancer Research: Tokyo, Japan
4. Cipponi A, Mercier M, Seremet T, Baurain JF, Theate I, van den Oord J, Stas M, Boon T, Coulie PG, van Baren N. (2012). Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res 72: 3997-4007
5. Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mule JJ. (2011). Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol 179: 37-45
6. Dejana E, Tournier-Lasserve E, Weinstein BM. (2009). The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221
7. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, Rabbe N, Laurans L, Tartour E, de Chaisemartin L, Lebecque S, Fridman WH, Cadranel J. (2008). Long-Term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 26: 4410-4417
8. Fridman WH, Pages F, Sautes-Fridman C, Galon J. (2012). The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12: 298-306
9. Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, Morikawa T, Okushiba S, Kondo S, Katoh H. (2004). CD8 tumorinfiltrating lymphocytes together with CD4 tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28: e26-e31
10. Girard JP, Moussion C, Forster R. (2012). HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12: 762-773
11. Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA, Porembka MR, Herndon JM, Eberlein TJ, Goedegebuure P, Linehan DC. (2010). Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 185: 4063-4071
12. Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, Rabie T, Kaden S, Grone HJ, Hammerling GJ, Arnold B, Ganss R. (2008). Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453: 410-414
13. Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674
14. Hayasaka H, Taniguchi K, Fukai S, Miyasaka M. (2010). Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci 101: 2302-2308
15. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. (2006). Prevalence of FOXP3 regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12: 5423-5434
16. Hiraoka N, Petryniak B, Nakayama J, Tsuboi S, Suzuki M, Yeh JC, Izawa D, Tanaka T, Miyasaka M, Lowe JB, Fukuda M. (1999). A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity 11: 79-89
17. Hruban RH, Boffetta P, Hiraoka N, Iacobuzio-Donahue C, Kato Y, Kern SE, Klimstra DS, Kloppel G, Maitra A, Offerhaus GJA, Pitman MB. (2010). Ductal adenocarcinoma of the pancreas. In World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Digestive System, Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) 4th edn, pp 281-291. IARC Press: Lyon, France
18. Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kanai Y, Hiraoka N. (2013). Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 108: 914-923
19. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP. (2011). Human solid tumors contain high endothelial venules: association with T-And B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 71: 5678-5687
20. Miyasaka M, Tanaka T. (2004). Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 4: 360-370
21. Nelson BH. (2010). CD20 B cells: the other tumor-infiltrating lymphocytes. J Immunol 185: 4977-4982
22. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Ruckert F, Grutzmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461
23. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK. (2011). Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35: 986-996
24. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L, Kolls JK, Khader SA, Randall TD. (2011). The development of inducible bronchus-Associated lymphoid tissue depends on IL-17. Nat Immunol 12: 639-646
25. Remark R, Alifano M, Cremer I, Lupo A, Dieu-Nosjean MC, Riquet M, Crozet L, Ouakrim H, Goc J, Cazes A, Flejou JF, Gibault L, Verkarre V, Regnard JF, Pages ON, Oudard S, Mlecnik B, Sautes-Fridman C, Fridman WH, Damotte D. (2013). Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res 19: 4079-4091
26. Sawada J, Urakami T, Li F, Urakami A, Zhu W, Fukuda M, Li DY, Ruoslahti E, Komatsu M. (2012). Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell 22: 235-249
27. Siegel R, Ward E, Brawley O, Jemal A. (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236
28. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. (2013). Innate lymphoid cells-A proposal for uniform nomenclature. Nat Rev Immunol 13: 145-149
29. van de Pavert SA, Mebius RE. (2010). New insights into the development of lymphoid tissues. Nat Rev Immunol 10: 664-674
30. von Andrian UH, Mempel TR. (2003). Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3: 867-878
31. Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB, Fukuda M. (2001). Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1, 3-N-Acetylglucosaminyltransferase. Cell 105: 957-969